The clinical challenge of onychomycosis.
Onychomycosis continues to be a difficult diagnosis to establish and treat. Better testing modalities need to be developed. Although new antimycotic agents [table: see text] are far more promising than previous treatments, relapse rates remain high. Patient education must be a mainstay of therapy. Establishing realistic expectations, providing a detailed treatment plan with follow-up, and reviewing preventive measures will enhance patient satisfaction and improve cure rates.
Meehan
K J
KJ
Department of Dermatology, US Naval Hospital, Agana, Guam.
Miller
C
C
D000284:Administration, Oral; D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008010:Lichen Planus / Q000175:diagnosis; D008297:Male; D009260:Nail Diseases / Q000175:diagnosis; D014009:Onychomycosis / Q000175:diagnosis* / Q000188:drug therapy*; D011379:Prognosis; D012008:Recurrence; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000935:Antifungal Agents